Biopharmaceutical compositions comprising nucleic acids encoding IL-5 binding proteins
US11976113B2 · kind B2 · utility
0Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 2020 |
| Grant date | May 7, 2024 |
| Priority date | — |
| Expiry date | Jan 15, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.